In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Toyama Chemical Co., Ltd.

http://www.toyama-chemical.co.jp/en

Latest From Toyama Chemical Co., Ltd.

TCMs Not Paxlovid Gain Traction As Beijing On High Alert

As Shanghai enters a second week of a city-wide lockdown with no signs of policy easing, officials are promoting the use of traditional Chinese medicines rather than Pfizer's recently approved Paxlovid.

China Coronavirus COVID-19

Aczone Generic Approval In Sight, All Clear At Sites Key To Torrent’s US Outlook

Torrent expects US FDA’s final approval for Allergan/Almirall’s Aczone, a dapsone formulation for acne vulgaris, in February, even as it awaits regulatory clearance for manufacturing sites. Meanwhile, it has launched molnupiravir in India and is hiking its domestic sales force by 400-500.

Approvals Sales & Earnings

ViGenCell’s Immune Cell Therapies To Get A Boost From $85M IPO

Korean bioventure ViGenCell successfully completes an IPO on the Kosdaq market with strong subscription rates from investors, reflecting the continued keen interest in biopharma shares in South Korea this year.

South Korea Financing

Chinese Firms Bag Most Latest Volume-Based Purchasing Wins

Domestic companies have won most of the bids in China's latest government procurement round for 62 drugs, marking an end to the previous dominance of off-patent products from multinationals.

China Market Access
See All

Company Information

  • Other Names / Subsidiaries
    • FUJIFILM Holdings Corporation
    • FUJIFILM Group
    • Cellular Dynamics International, Inc.
    • Opsis Therapeutics
UsernamePublicRestriction

Register